Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.
about
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human HealthCurrent tecniques and new perpectives research of magnetic resonance enterography in pediatric Crohn's diseaseUrinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical reviewEmerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseMRI for Crohn's Disease: Present and FutureReview: toxicometabolomicsMicrobiome, Metabolome and Inflammatory Bowel DiseaseContribution of metabolic reprogramming to macrophage plasticity and functionGenome-wide association study of metabolic traits reveals novel gene-metabolite-disease linksDietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study.Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.Systems biology of host-microbe metabolomics.Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in RemissionUrine metabolome profiling of immune-mediated inflammatory diseases.Metabolomics: is it useful for inflammatory bowel diseases?Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity.Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseasesProteomics and metabolomics in inflammatory bowel disease.NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.Metabolomics as a diagnostic tool in gastroenterology.Metabonomics exposes metabolic biomarkers of Crohn's disease by (1)HNMR.Predicting outcomes in acute severe ulcerative colitis.Review article: breath analysis in inflammatory bowel diseases.Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation.HORSE SPECIES SYMPOSIUM: Canine intestinal microbiology and metagenomics: From phylogeny to function.Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.1H NMR based metabolic profiling in Crohn's disease by random forest methodology.Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer.Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.Metabolomic profile of systemic sclerosis patients.Emerging concepts in non-invasive monitoring of Crohn's disease.
P2860
Q26738283-5570A6FE-43C5-4137-9F53-63DC298ABE1EQ26739755-3CF10D4F-6CC2-4156-8741-697F47E4D255Q26748735-4CA4ED9B-7494-43F5-B624-A35DF07E2FBDQ26768273-7C3281EF-74D5-4CF1-8422-CDC65C405D42Q26785603-987BB957-795C-4CC7-A340-1A5D909E1FA8Q27001191-1BA6C0AA-5701-402D-8B87-38A1C417DAA1Q28078126-19CE42A6-0014-4656-9180-76BB12C9FF21Q28080959-90E1169B-08FB-4EE2-B125-64423795446FQ28539941-69B5F756-47CB-4E11-9987-0F1A5EC98C0AQ33786052-96BB2AC6-AF89-44F6-B6E1-4D5B7568CA85Q34900690-F06AE4AA-A802-4F0E-8D46-34EBE842E0E2Q35619563-4483E804-9795-44BC-926B-08C508896E41Q35810516-6F13940D-B5A5-4213-9440-2E97D6CD8BB4Q36127459-0615B5D5-0BFC-4388-B7C2-2565319209CFQ36955885-8EEA8E42-6479-461F-8008-D8CCB71478D0Q37210128-5B299E71-5EB9-4783-A9AC-29D82593FF9EQ37454433-08E55699-B87A-40C5-9EC7-B33F2818295CQ38089179-C6EC21DC-FEE9-46A4-979E-7F9026B4CC81Q38119451-49FD2241-D4E5-49DB-8442-18B66463D022Q38160492-9F61E7FF-8929-42E0-B23B-DC5A5973096CQ38212243-8382E63B-A75B-43A0-A347-EFBCD0F09EF4Q38286166-3A6ADD91-9A17-4B25-BBDF-184F56914595Q38293574-FDF12B5A-FD4B-4D45-8D2E-8454DEA526A5Q38617974-62754E6A-0C22-4DB3-8AA6-B90A81286C72Q38861231-27EA1688-B2A5-4104-BA4F-425407F5772FQ40066779-8A3EF3D9-AE32-4200-8B00-35399BF75FEEQ42237462-53DB67B0-4B14-4C41-A9B7-C3B929A61FD5Q43551236-7707B4F6-63DA-46FE-A770-160F02C2B575Q46964998-6F76D50A-E557-487F-935E-FF8B8F824589Q47110549-42CF929C-5FF2-48C4-91D7-037C81DD4ADBQ48791026-E61CD472-BB16-48D0-BCF4-F5759DF8C45FQ55191669-966A2739-826A-4F61-947F-EFEB7914DF44Q55364545-39E3B738-9EB0-474A-831A-544DFC903A0C
P2860
Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.
@en
type
label
Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.
@en
prefLabel
Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.
@en
P2093
P2860
P1476
Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.
@en
P2093
Carolyn M Slupsky
Jesse Siffledeen
Natasha S Stephens
Richard N Fedorak
Travis B Murdoch
Xiaorong Su
P2860
P356
10.1016/J.CROHNS.2012.04.019
P577
2012-05-22T00:00:00Z